Comments
Diagnostic services provider Dr Lal Path Labs on Thursday said its consolidated net profit declined 57 per cent to ₹58 crore for the first quarter ended June 30, 2022.
The company had reported a net profit of ₹134 crore in the April-June period of the last fiscal.
Revenue from operations declined to ₹503 crore in the period from ₹607 crore a year ago, Dr Lal PathLabs said in a regulatory filing.
The company's board has also declared an interim dividend of ₹6 per share for the current fiscal.
Shares of the company were trading 1.27 per cent down at ₹2,142.7 apiece on BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.